Clinical Trials Directory

Trials / Completed

CompletedNCT03622502

The Effect of Dexmedetomidine for Emergence Cough

The Effect of Dexmedetomidine on the Remifentanil Concentration for Preventing Cough During Emergence After Propofol Anesthesia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Ajou University School of Medicine · Academic / Other
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Dexmedetomidine or remifentanil are effective in attenuating cough during peri-extubation period after general anesthesia. The purpose of this study was to investigate the effect of dexmedetomidine on the remifentanil concentration for the cough suppression during anesthetic emergence.

Detailed description

Administration of dexmedetomidine before end of surgery could reduce airway reflexes and hemodynamic changes during tracheal extubation. Compared with remifentanil alone, administration of dexmedetomidine in combination with remifentanil is effective in relieving cough and hemodynamic changes without inhibition of respiration. The purpose of this study was to investigate the effect of dexmedetomidine on the remifentanil concentration for the cough suppression during anesthetic emergence using the modified up-and-down method.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineDexmedetomidine 0.5mcg/kg was infused over 10 min before end of the surgery
DRUGRemifentanilRemifentanil was maintained at predetermined effect-site concentration during the periextubation period (initial concentration: 2.0 ng/ml)
DRUGNormal salineNormal saline was infused over 10 min before end of the surgery

Timeline

Start date
2018-08-16
Primary completion
2019-03-22
Completion
2019-03-27
First posted
2018-08-09
Last updated
2020-01-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03622502. Inclusion in this directory is not an endorsement.